Antiplatelet Drugs Market 2019: Global Key Players, Trends, Share, Industry Size, Segmentation, Opportunities, Forecast To 2025

Summary: A new market study, titled “Discover Global Antiplatelet Drugs Market Upcoming Trends, Growth Drivers and Challenges” has been featured on WiseGuyReports.

Pune, India - September 20, 2019 /MarketersMedia/ —

Introduction

Global Antiplatelet Drugs Market

Antiplatelet medicines come under the group of powerful medicine which can effectively avert blood clots. When a person is wounded, the platelets reach the injured area and combine to create a clot and reduce the bleeding. This is something good when some injuries involve a break in the skin. However, it has seen that platelets can also combine when in damage to the blood vessel arises from the inside of the body. In such condition, the platelets lead to blood clots in the injured artery. So, Antiplatelets drugs can help by preventing this condition.

Different studies have proved that such drugs are quite useful in preventing angina, heart attack, peripheral artery disease, TIAs- Transient Ischemic Attacks, and more. Besides, the medicines are used after different surgeries, for example, stent surgeries, bypass surgeries, and more. As the number of such cases increasing rapidly, the demand for Antiplatelet Drugs also has increased. The growth of Antiplatelet Drugs Market is majorly due to the changing lifestyles has increased the examples of heart issues. WHO says around 15 to 18 million people across the globe are suffering from heart diseases ever year.

The new scenario reveals to prevent angina, TIAs and more such condition; people are using such drug. So, the Global Antiplatelet Drugs Market, which was valued at $ xx million in the years 2018, by the end of 2025 will reach USD xx million. Besides, the CAGR- Compound Annual Growth Rate will be xx percent. This is a good indication for such drugs market.

 

Get Free Sample Report at https://www.wiseguyreports.com/sample-request/3791985-global-antiplatelet-drugs-market-2018-2025

 

Global Antiplatelet Medicines Market Segmentation

The World Antiplatelet Medicines marker has segmented by Type and Mode of Administration.

Talking about medicine Type, it has split into Prasugrel, Clopidogrel, Cangrelor, Aspirin, Ticagrelor, Abciximab, and more. The primary product which dominates the market is Aspirin. The reason behind this is it reduces deaths attributable to myocardial infarction.

Now, coming to Mode of Administration, there are Oral and Intravenous. Oral administration has a major share. Intravenous administration is generally used in emergency cases.

 

Geographical Segmentation of Global Antiplatelet Medicines Market

Considering the geography, the Global Antiplatelet Drugs Market market has segmented into South America, Europe, North America, Asia Pacific and Rest of the world.

As per the report, North America is dominating the global market. The reasons behind these are rising prevalence of cardiovascular diseases and increasing aging population. After North America, there are the Asia Pacific and Europe. The rate of investment in Research and Development in these regions has gone up.

 

Key Players of Global Antiplatelet Drugs Market =>

The major players who are ruling the World Antiplatelet Drugs Market are Bayer Pharmaceuticals, Hoffmann La Roche, AstraZeneca, Bristol- Myers Squibb Company, Mylan Pharmaceutical, Sanofi, Boehringer Ingelheim Pharmaceuticals, Pfizer Inc and Teva Pharmaceuticals, Merck & Co., Inc.

 

Latest News

As per the report, recently, the FDA has given green signal to Bayer Pharmaceuticals’ therapy designed for a significant novel reversal agent for the antiplatelet drugs. Besides, the company has acquired some new drugs development technology to come up with high-quality medications to treat heart diseases.

 

Get Detailed Report at https://www.wiseguyreports.com/reports/3791985-global-antiplatelet-drugs-market-2018-2025

 

Contact Info:
Name: Norah Trent
Email: Send Email
Organization: WISE GUY RESEARCH CONSULTANTS PVT LTD
Website: http://www.wiseguyreports.com

Source URL: https://marketersmedia.com/antiplatelet-drugs-market-2019-global-key-players-trends-share-industry-size-segmentation-opportunities-forecast-to-2025/88921147

Source: MarketersMedia

Release ID: 88921147

Latest News

China criticizes Apple for app that tracks Hong Kong police

Oct 18, 2019

HONG KONG — Apple became the latest company targeted for Chinese pressure over protests in Hong Kong after the ruling Communist Party's main newspaper criticized the tech giant Wednesday for a smartphone app that allows activists to report police movements. HKmap.live, designed by an outside supplier and available on Apple Inc.'s online store, "facilitates illegal behavior," the People's Daily said in a commentary. "Is Apple guiding Hong Kong thugs?" the newspaper said. Beijing has pressed companies including Hong Kong's Cathay Pacific Airways to take the government's side against the protests, which are in their fourth month. Apple didn't immediately respond...

China lets currency sink to 11-year low after Trump threats

Oct 18, 2019

BEIJING — China allowed its yuan to sink to an 11-year low Monday after President Donald Trump sent jittery financial markets tumbling by announcing new tariff hikes and threatening to block American companies from doing business with this country. The escalation in the fight over trade and technology prompted warnings that chances for a settlement were disappearing. The yuan declined to 7.1468 to the dollar, a relatively modest change from Friday's low point of 7.0927 but its weakest rate since January 2008. The yuan has lost 6.5% from this year's high on Feb. 28. Chinese leaders have promised to avoid...

China threatens retaliation if US tariff hikes go ahead

Oct 18, 2019

BEIJING — China on Thursday threatened retaliation if Washington steps up their war over trade and technology by going ahead with planned Sept. 1 tariff hikes on additional Chinese imports. Beijing will take unspecified "necessary countermeasures," the Cabinet said in a one-sentence statement. It gave no details or any indication plans for trade talks in Washington in September might be affected. The mounting tension has unnerved financial markets that worry the global economy will tip into recession. President Donald Trump says he plans to impose 10% duties on an additional $300 billion of Chinese imports, extending penalties to almost everything...

China's Xi gets tougher on Trump after new tariff threat

Oct 18, 2019

BEIJING — Facing another U.S. tariff hike, Chinese President Xi Jinping is getting tougher with Washington instead of backing down. Beijing fired what economists called a "warning shot" at Washington by letting its yuan currency weaken in response to President Donald Trump's latest threat of more punitive import duties on Sept. 1. Chinese buyers canceled multibillion-dollar purchases of U.S. soybeans. Regulators are threatening to place American companies on an "unreliable entities" list that might face curbs on their operations. Both sides have incentives to settle a trade war that is battering exporters on either side of the Pacific and threatening...

US says new round of talks with China were 'constructive'

Oct 18, 2019

SHANGHAI — U.S. and Chinese envoys held "constructive" trade talks on Wednesday, the White House said, after President Donald Trump rattled financial markets by accusing Beijing of trying to stall in hopes he will fail to win reelection in 2020. The meeting, aimed at ending a tariff war over trade and technology, ended about 40 minutes ahead of schedule. Neither delegation spoke to reporters before U.S. Trade Representative Robert Lighthizer and Treasury Secretary Steven Mnuchin left for the airport. But White House spokeswoman Stephanie Grisham said in a statement hours later that "the meetings were constructive," and that talks are...

Scienfinite is created to inspire our readers with the aim to understand the world and appreciate its everyday awe. Keep up with the technology and latest innovations here, only in Scienfinite.